Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias

4Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Amino acid (AA) metabolism plays an important role in many cellular processes including energy production, immune function, and purine and pyrimidine synthesis. Cancer cells therefore require increased AA uptake and undergo metabolic reprogramming to satisfy the energy demand associated with their rapid proliferation. Like many other cancers, myeloid leukemias are vulnerable to specific therapeutic strategies targeting metabolic dependencies. Herein, our review provides a comprehensive overview and TCGA data analysis of biosynthetic enzymes required for non-essential AA synthesis and their dysregulation in myeloid leukemias. Furthermore, we discuss the role of the general control nonderepressible 2 (GCN2) and-mammalian target of rapamycin (mTOR) pathways of AA sensing on metabolic vulnerability and drug resistance.

Cite

CITATION STYLE

APA

Bhingarkar, A., Vangapandu, H. V., Rathod, S., Hoshitsuki, K., & Fernandez, C. A. (2021, July 1). Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.694526

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free